Continent’s top firms drove most of European equity gains last year
Novo Nordisk
Pan-European Stoxx 600 extends gains and hit a fresh record high, rising 1 per cent
Drug maker trades on multiples unheard of in pharma sector over anticipated sales of weight loss drug
Stocktake: Europe’s most valuable company last week exceeded a market value of $500bn after reporting better-than-expected earnings
The drug maker has struggled to keep up with demand for both Wegovy and Ozempic
From flight cancellation misery and forfeited pay to corporation tax hauls and obesity drug bonanzas, everything in 2023 had either a value or a cost
News of new factory comes after Danish group announced in December the purchase of drug manufacturing plant in Athlone in order to keep up with demand for weight-loss drugs
Pharmaceutical giant suffers a post-Covid-19 hangover as demand for pandemic vaccines and medicines falls sharply
Danish weight loss and diabetes specialist is looking to develop a tablet form of its blockbuster obesity treatments
Proposals would lower time period a company has protection over research behind drugs they develop
Correspondence between health officials details 'high level of concern' about obesity drug shortages
Helge Lund has sought to reassure investors following Looney’s abrupt departure
Company boosted by trial results showing weight loss drug also cuts risk of heart attack by 20%
Planet Business: Pre-Swift concert film hits, Qantas’s under-fire chairman, and the ascent of Novo Nordisk
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices